1. Introduction
Elephantiasis, medically known as lymphatic filariasis, is a neglected tropical disease caused by filarial nematodes—primarily Wuchereria bancrofti, Brugia malayi, and Brugia timori. Transmitted via mosquitoes, the infection leads to progressive damage to the lymphatic system, culminating in lymphedema and often disfiguring enlargement of body parts (WHO, 2025a; Cleveland Clinic, 2025).
2. General Pathophysiology and Commonly Affected Regions
2.1 Mechanism of Tissue Swelling
Adult worms lodge in lymphatic vessels and lymph nodes, causing obstruction, lymph stasis, and immune-mediated inflammation (WHO, 2025a; Shenoy, 2008). Chronic disruption of lymph circulation triggers lymphedema, and with recurrent bacterial infections—especially streptococcal cellulitis—progresses to skin and tissue thickening characteristic of elephantiasis (Shenoy, 2008; WHO, 2025a).
2.2 Limbs: Predominant Sites
Lower limbs are the most frequently afflicted areas. Lymphedema initially affects distal extremities, particularly legs, and may extend to arms. Over time, fibrosis, skin thickening, and deformity ensue. Brugia malayi especially tends to involve distal extremities (WHO, 2025b; Wikipedia, 2025).
2.3 Breasts
In women, elephantiasis can involve breasts—a manifestation of lymph stasis and skin fibrosis (Shenoy, 2008; Cleveland Clinic, 2025). This form may be less common but contributes significantly to morbidity and stigma.
3. Genital Involvement: Private Parts and Related Manifestations
3.1 Male Genitalia: Scrotum, Penis (Hydrocele & Chyloderma)
-
Hydrocele: A hallmark of chronic lymphatic filariasis in males, this condition involves fluid accumulation within the scrotum due to lymphatic obstruction by Wuchereria bancrofti (WHO, 2025a). Globally, tens of millions of men are affected, severely impacting quality of life (Verywell Health, 2018; Guardian, 2024).
-
Chyloderma (Elephantiasis scroti): More advanced than hydrocele, chyloderma involves chronic lymphatic blockage resulting in marked swelling and fibrosis of the scrotal tissue (Chyloderma, 2025).
3.2 Penis and Vulva
Both the penis and vulva may demonstrate edema, lymphatic swelling, and eventual elephantiasis (Cleveland Clinic, 2025; WHO, 2025a). In females, vulvar elephantiasis is a significant morbidity, often resulting in disfigurement, sexual dysfunction, and stigma; however, incidence appears lower compared to male genital involvement (Cleveland Clinic, 2025; WHO, 2025a).
4. Pathogen-Specific Patterns & Less Common Sites
4.1 Wuchereria bancrofti
Responsible for ~90% of cases, this species affects lower limbs, arms, breasts, and male genitalia prominently (Bancrofti, 2025; Filariasis, 2025). It accounts for widespread genital involvement, including hydrocele and penile/vulvar elephantiasis.
4.2 Brugia malayi
This parasite typically causes elephantiasis in the distal extremities and rarely involves genital regions. It does not commonly cause hydrocele, funiculitis, or chyluria (Brugia malayi, 2025).
4.3 Brugia timori
Genital involvement is rare with B. timori, though data are less extensive. It mainly causes lower limb edema (Filariasis, 2025).
4.4 Other Rare Sites
Elephantiasis of the face, ears, mucosal surfaces, or amputation stumps is uncommon but documented. These atypical sites are seldom involved and are more anecdotal in literature (Filariasis, 2025).
5. Summary Table: Anatomical Sites by Filarial Species
| Anatomical Region | W. bancrofti | B. malayi | B. timori |
|---|---|---|---|
| Lower limbs (legs) | Commonly affected (elephantiasis) | Common (distal extremities) | Common |
| Upper limbs (arms) | Affected | Less frequently reported | Rare |
| Breasts (females) | Involvement possible | Rare/uncommon | Uncommon |
| Scrotum (Hydrocele, Chyloderma) | Very common; hydrocele, chyloderma | Rare | Rare |
| Penis/Vulva | Potentially involved | Rare | Rare |
| Face, Ears, Mucosa | Very rare | Very rare | Very rare |
6. Clinical Implications: Morbidity, Stigma, and Treatment Considerations
Elephantiasis, particularly of private parts, carries profound socio-economic and psychological burdens. Swollen genitals can impede mobility, daily life, marital relations, and can cause intense stigma and distress (WHO, 2025a; Guardian, 2024).
Management includes:
-
Medical treatment with antifilarial agents (e.g., diethylcarbamazine, albendazole, ivermectin) to reduce microfilariae and limit transmission (WHO, 2025b; Wikipedia—Filariasis, 2025).
-
Morbidity management and disability prevention (MMDP): hygiene, skin care, exercise to reduce lymphedema, and psychological support (WHO, 2025a; Shenoy, 2008).
-
Surgery: hydrocele repair and, in selected cases, procedures to reduce genital elephantiasis (Guardian, 2024; WHO, 2025a).
7. Conclusion
Elephantiasis affects multiple body regions, prominently lower limbs, with noteworthy involvement of genitalia, especially in males. The specific anatomical distribution depends on the filarial species involved: Wuchereria bancrofti exhibits the broadest regional involvement, including legs, arms, breasts, and genitalia; Brugia malayi largely remains limited to distal extremities without genital manifestation; Brugia timori shares a similar pattern. Rarely, unusual sites such as the face or ear may be involved. Recognition of these patterns is essential for holistic diagnosis, tailored therapeutic strategies, and psychosocial interventions.
References
- Cleveland Clinic. (2025) Lymphatic Filariasis (Elephantiasis): Causes, Symptoms & Treatment. Available at: [Cleveland Clinic website] (Cleveland Clinic).
- Guardian. (2024) 'Growth the size of a melon: a scrotum-swelling disease threatening thousands', The Guardian, 25 October. (The Guardian).
- Shenoy, R.K. (2008) 'Clinical and Pathological Aspects of Filarial Lymphedema and Its Management', Korean Journal of Parasitology, 46(3), pp. 119–125. (PMC).
- WHO (World Health Organization). (2025a) Lymphatic Filariasis: Fact sheet. Available at: [WHO]. (World Health Organization).
- WHO (World Health Organization). (2025b) Lymphatic filariasis detection, prevention and control [internet]. Published 21 November 2024. Available at: [WHO]. (World Health Organization).
